Interestingly, we found a greater number of BST2, HLA-E, PD-L1, and PDPN positive GFAP+ astrocytes in AD post-mortem brains compared to brains from non-symptomatic individuals, warranting further investigations on the roles that these markers play in neurodegenerative disease. This evidence concerns the gene GFAP and Alzheimer disease.